Lubrizol Life Sciences

Activities: Manufacturing Ingredients

The Health business of Lubrizol Life Science (LLS Health), in partnership with customers, advances solutions inspiring a healthier life. We specialize in helping clients from idea to execution by offering innovative polymers and excipients, as well as best-in-class contract development and manufacturing services. Our long history of polymer expertise and continued investment in research and manufacturing means we offer you and your customers a smooth and streamlined approach to innovative healthcare solutions.

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Ingredients

Lubrizol’s Apisolex Polymer wins Finished Formulation Award at CPhI Barcelona

The solubility-enhancing excipient for injectable drug formulations has won the prestigious CPhI Barcelona award
Regulatory

Lubrizol licenses novel excipient polymer technology to Welton Pharma

Introduced to the market last year, the patented Apisolex excipient is a polyamino-acid polymer designed for parenteral applications
Media

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a number of hurdles and opportunities. A panel of industry experts examine how the slings and arrows of the past twelve months might affect the next ten years
Regulatory

Women’s Equality Day: Pharma is levelling the playing field

Barbara Morgan, Pharmaceutical Business Director at Lubrizol Life Science Health, reflects on the issue of gender equality and the importance of an inclusive approach
Packaging

Lubrizol acquires German medical device manufacturer BMT

Bavaria Medizin Technologie offers private label manufacturing and OEM services such as sterilisation, packaging, and logistics management
Subscribe now